Last updated on March 2019

A Study to Evaluate the Pharmacokinetics Safety and Tolerability of Intravenous Brivaracetam in Subjects >= 1 Month to < 16 Years of Age With Epilepsy


Brief description of study

The purpose of the study is to evaluate the pharmacokinetics (PK), safety, and tolerability of brivaracetam (BRV) administered intravenously (iv) in subjects >= 1 month to < 16 years of age with epilepsy.

Clinical Study Identifier: NCT03405714

Find a site near you

Start Over

Ep0065 108

Gulf Breeze, FL United States
  Connect »

Ep0065 103

Loxahatchee Groves, FL United States
  Connect »

Ep0065 221

San Antonio, TX United States
  Connect »

Ep0065 232

Miskolc, Hungary
  Connect »

Ep0065 248

Sevilla, Spain
  Connect »

Ep0065 225

Bethesda, MD United States
  Connect »

Ep0065 233

New Brunswick, NJ United States
  Connect »

Ep0065 224

Budapest, Hungary
  Connect »

Ep0065 222

Debrecen, Hungary
  Connect »

Ep0065 102

Akron, OH United States
  Connect »

Ep0065 228

Balassagyarmat, Hungary
  Connect »

Ep0065 210

Budapest, Hungary
  Connect »

Ep0065 243

Los Angeles, CA United States
  Connect »

Ep0065 237

Durham, NC United States
  Connect »

Ep0065 240

Praha 4, Czechia
  Connect »

Ep0065 254

Bielefeld, Germany
  Connect »

Ep0065 247

Budapest, Hungary
  Connect »

Ep0065 244

San Bernardino, CA United States
  Connect »

Ep0065 252

Bronx, NY United States
  Connect »

Ep0065 229

Florence, Italy
  Connect »

Ep0065 231

Praha 5, Czechia
  Connect »

Ep0065 502

Hradec Králové, Czechia
  Connect »

Ep0065 242

Berlin, Germany
  Connect »

Ep0065 219

Catania, Italy
  Connect »